Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proellex in symptomatic uterine fibroids
NCT02301897Phase 2Completed
- Sponsor
- Repros Therapeutics Inc.
- Start
- Mar 2015
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of telapristone in Uterine Fibroids (UF), sponsored by Repros Therapeutics Inc.. Started Mar 2015; status: completed.
02
Drugs
telapristone
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT02301897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02301897.